AM2018 PAN20 Defining the Clinical Target Volume: From the Art to the Science

The definition of the clinical target volume (CTV) is becoming the weakest link in the radiotherapy chain. In this session we will first review some of the challenges of the standard CTV definition process (the "art"). We will then present new approaches that are being developed to move CTV definition from an art to a science. These include advances in imaging to make the invisible CTV extension visible, advances in machine learning to support the clinician in defining the CTV, and developments in robust treatment planning to incorporate uncertainties of the CTV in the treatment planning process.

Target Audience

The meeting is designed to meet the interests of radiation oncologists, radiation physicists, diagnostic radiologists, and radiation biologists.

Learning Objectives

  • Explain how machine learning tools can help to define the clinical target volume.
  • Explain how uncertainties in defining the clinical target volume can be included in the treatment planning process through sensitivity analysis and robust optimization.
Course summary
Available credit: 
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

Course opens: 
10/01/2018
Course expires: 
11/12/2018
Cost:
$0.00
Rating: 
0

The following persons serve as faculty for this activity: Anca Grosu, MD, Robert Jeraj, PhD, Laurence Court, PhD, and Thomas Bortfeld, PhD.

Additionally, the SA-CME Task Force and CME/MOC Committee had control over the content of this activity.

Disclosure link: 
Committee Disclosures

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

Price

Cost:
$0.00
Please login or register to take this course.

Policies: 

  • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
  • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
  • ASTRO staff cannot make modifications to your submitted materials.
     

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.